Drug – bio-affecting and body treating compositions – Antigen – epitope – or other immunospecific immunoeffector – Amino acid sequence disclosed in whole or in part; or...
Patent
1995-06-07
1998-06-02
Cunningham, Thomas M.
Drug, bio-affecting and body treating compositions
Antigen, epitope, or other immunospecific immunoeffector
Amino acid sequence disclosed in whole or in part; or...
4241981, 514 2, 514 12, 435 696, 530380, A61K 3936, C07K 14745
Patent
active
057595470
ABSTRACT:
The subject invention pertain to methods of treating Kaposi's Sarcoma and ocular neovascularization using rPF4 and angiogenesis-inhibiting fragments of rPF4.
REFERENCES:
patent: 4645828 (1987-02-01), Twardzik et al.
patent: 4737580 (1988-04-01), Twardzik et al.
patent: 5086164 (1992-02-01), Maione et al.
patent: 5112946 (1992-05-01), Maione
patent: 5248666 (1993-09-01), Twardzik et al.
patent: 5284827 (1994-02-01), Maione et al.
Folkman, J. et al., Ciba Found. Sympos. 100:132-149 (1983), "The role of heparin in angiogenesis".
Folkman, J., Cancer Invasion and Metastasis, pp. 201-208 (1984), "Angiogenesis: initiation and modulation".
Folkman, J., M. Klagsbrun (1987) "Angiogenic Factors" Science 235:442-447.
Taylor, S., J. Folkman (1982) "Protamine is an inhibitor of angiogenesis" Nature 297:307-312.
Deuel, T.F. et al. (1981) "Platelet factor 4 is chemotactic for neutrophils and monocytes" Proc. Natl. Acad. Sci. USA 78(7):4585-4587.
Osterman, D.G. et al. (1982) "The carboxyl-terminal tridecapeptide of platelet factor 4 is a potent chemotactic agent for monocytes" Biochem. and Biophys. Res. Comm. 107(1):130-135.
Wolpe, S.D., A. Cerami (1989) "Macrophage inflammatory proteins 1 and 2: members of a novel superfamily of cytokines" FASEB Journal 3:2565-2573.
Cotran, R.S. et al. (1989) "Female Genital Tract" Robbins Pathologic Vasis of Disease, 4 Edition, pp. 1146-1159.
Maione, T.E. et al. (1991) "Inhibition of Tumor Growth in Mice by an Analogue of Platelet Factor 4 That Lacks Affinity for Heparin and Retains Potent Angiostatic Activity" Cancer Research 51:2077-2083.
Cunningham Thomas M.
Repligen Corporation
LandOfFree
Methods and compositions for treatment of angiogenic diseases does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Methods and compositions for treatment of angiogenic diseases, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Methods and compositions for treatment of angiogenic diseases will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1456619